3rd blood pressure drug recalled in recent weeks over impurity

Henrietta Strickland
November 17, 2018

As per the FDA, the latest recall has impacted less than 1% of the total products of losartan drug all over the USA market. Because not all valsartan and irbesartan drugs are involved in the recall, you might be able to switch to a version by another company. Ltd. Sandoz Inc. Losartan Potassium Hydrochlorothiazide product is manufactured by Lek Pharmaceuticals dd, Ljubljana, Slovenia.

The recall includes 100 milligram/25 milligram tablets with the lot number JB8912.

According to Sandoz, the N-nitrosodiethylamine impurity is a naturally occurring substance that is found in some foods, drinking water, air pollution, and industrial processes.

According to the FDA, Losartan Potassium-Hydrochlorothiazide Tablets, USP are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents. The blood pressure medication was distributed nationwide after October 8, 2018.

This product was distributed nationwide to distributors.

This is the third blood pressure medication to face recall as of late.

Sandoz has notified distributors and patients in a letter of the recall.

The US FDA has said that another medicine for the heart is getting recalled in a voluntary manner.

Patients who are now on the medication are advised to talk to their doctor before stopping use. Patients should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using Losartan Potassium Hydrochlorothiazide. However, if you have any drugs in your consumption list which got affected by this recall, then it's advisable for you to get alternative medicine under doctor's prescription.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER